| Financial Year |
March 31 2023 |
| Monetary Funds |
10,583,437,323.40 |
| Held-for-trading Financial Assets |
33,410,169.63 |
| Notes Receivable |
25,455,042.31 |
| Accounts Receivable |
2,673,022,162.98 |
| Advances to Suppliers |
229,370,084.81 |
| Other Receivables |
824,110,984.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
33,055,090,265.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,071,133,526.13 |
| Total Current Assets |
61,718,999,872.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
238,416,793.29 |
| Long-term Equity Investment |
143,654,944.76 |
| Investment Properties |
3,124,863,466.59 |
| Fixed Assetes |
475,998,417.21 |
| Under-construction Projects |
20,327,779.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,559,517,220.22 |
| R&D expenses |
-- |
| Goodwill |
19,450,550.74 |
| Long-Term Deferred and Prepaid Expenses |
189,922,631.29 |
| Deferred Income Tax Assets |
1,555,264,874.06 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
8,320,886,664.52 |
| Total Assets |
70,039,886,536.84 |
| Short-Term Loans |
4,372,855,042.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,104,115,598.33 |
| Accounts Payable |
16,402,489,141.40 |
| Accounts Received In Advance |
34,941,372.34 |
| Employee Compensation Payable |
666,376,174.45 |
| Taxes Payable |
661,640,731.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,834,430,358.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,702,691,459.31 |
| Other Current Liabilities |
3,637,274,327.09 |
| Sub-Total of Current Liabilities |
43,726,251,173.67 |
| Long-term Loans |
9,938,804,043.43 |
| Bonds Payable |
1,465,300,000.00 |
| Long-Term Accounts Payable |
5,083,585.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,652,665.63 |
| Deferred Income Tax Liabilities |
137,360,379.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,878,105,420.33 |
| Total Liabilities |
55,604,356,594.00 |
| Paid-In Capital(Or Share Stock) |
1,868,545,434.00 |
| Capital Surplus |
1,562,951,153.81 |
| Surplus Reserve |
934,272,717.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,165,783,405.58 |
| Minority Stockholder's Interest |
432,132,507.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,003,397,435.33 |
| Owner's Equity（Stockholder's Equity） |
14,435,529,942.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
70,039,886,536.84 |
